Pesquisas alternativas:
daily compared » elderly compared (Expandir a Pesquisa)
adl computers » aids computers (Expandir a Pesquisa), do computers (Expandir a Pesquisa), a computers (Expandir a Pesquisa)
computers dan » computers can (Expandir a Pesquisa), computers data (Expandir a Pesquisa), computers a (Expandir a Pesquisa)
nacl compared » al compared (Expandir a Pesquisa), panel compared (Expandir a Pesquisa), tool compared (Expandir a Pesquisa)
compared dan » compared can (Expandir a Pesquisa), comparee dans (Expandir a Pesquisa), compared a (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared can (Expandir a Pesquisa), compared _ (Expandir a Pesquisa)
dan non » dan ning (Expandir a Pesquisa)
2 daily » _ daily (Expandir a Pesquisa), a daily (Expandir a Pesquisa), d daily (Expandir a Pesquisa)
j nacl » _ nacl (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa), a nacl (Expandir a Pesquisa)
i adl » _ adl (Expandir a Pesquisa), i all (Expandir a Pesquisa), i adh (Expandir a Pesquisa)
daily compared » elderly compared (Expandir a Pesquisa)
adl computers » aids computers (Expandir a Pesquisa), do computers (Expandir a Pesquisa), a computers (Expandir a Pesquisa)
computers dan » computers can (Expandir a Pesquisa), computers data (Expandir a Pesquisa), computers a (Expandir a Pesquisa)
nacl compared » al compared (Expandir a Pesquisa), panel compared (Expandir a Pesquisa), tool compared (Expandir a Pesquisa)
compared dan » compared can (Expandir a Pesquisa), comparee dans (Expandir a Pesquisa), compared a (Expandir a Pesquisa)
compared law » compared a (Expandir a Pesquisa), compared can (Expandir a Pesquisa), compared _ (Expandir a Pesquisa)
dan non » dan ning (Expandir a Pesquisa)
2 daily » _ daily (Expandir a Pesquisa), a daily (Expandir a Pesquisa), d daily (Expandir a Pesquisa)
j nacl » _ nacl (Expandir a Pesquisa), 3 nacl (Expandir a Pesquisa), a nacl (Expandir a Pesquisa)
i adl » _ adl (Expandir a Pesquisa), i all (Expandir a Pesquisa), i adh (Expandir a Pesquisa)
1
Por Galán, Iñaki, Mata, Nelva, Estrada, Carmen, Díez-Gañán, Lucía, Velázquez, Luis, Zorrilla, Belén, Gandarillas, Ana, Ortiz, Honorato
Publicado em 2007
“... the law came into force the OR for daily exposure > 0–3 hours versus non-exposure was 0.11 (95% CI: 0.07...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Nguyen, Ngoc Bich, Capra, Mike, Johnstone, Kelly, Vu, Hoang Lan, Tran, Vu, Nguyen, Minh Tham, Nguyen, Kim Ngan, Cook, Margaret
Publicado no Environ Health Insights (2020)
“... study of staff at 4 universities were conducted in 2 phases, Phase 1 as early introduction of the Law (n...”Publicado no Environ Health Insights (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“...In this study, we propose an evolution law of COVID-19 transmission. An infinite ordered lattice...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Bays, Harold E, Weinstein, Richard, Law, Gordon, Canovatchel, William
Publicado no Obesity (Silver Spring) (2014)
“... compared with placebo (least squares mean percent changes from baseline of −2.2%, −2.9%, −2.7%, and −1...”Publicado no Obesity (Silver Spring) (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“... cross-area 2 (MCA2) was measured by acoustic rhinometry at 1, 4, 8, and 12 minutes after NPT for each...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Psota, Marek, Psenkova, Maria Bucek, Racekova, Natalia, Ramirez de Arellano, Antonio, Vandebrouck, Tom, Hunt, Barnaby
Publicado no Clinicoecon Outcomes Res (2017)
“...AIMS: To investigate the cost-effectiveness of once-daily insulin degludec/liraglutide (IDegLira...”Publicado no Clinicoecon Outcomes Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Verros, Stergios, Lucassen, Koen, Hekman, Edsko E. G., Bergsma, Arjen, Verkerke, Gijsbertus J., Koopman, Bart F. J. M.
Publicado no PLoS One (2019)
“... devices may present a solution for people with DMD to perform activities of daily living (ADL). One...”Publicado no PLoS One (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Chen, Yen-Yuan, Gordon, Nahida H, Connors, Alfred F, Garland, Allan, Chang, Shan-Chwen, Youngner, Stuart J
Publicado em 2014
“... and 2,051 non-DNR patients. The daily cost of intensive care unit (ICU) stay, the daily cost of hospital...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... with grades I and II NP were consecutively treated with oral prednisolone at 25 mg in a single dose for 2...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Verónica Sambra, Sandra López-Arana, Paola Cáceres, Karen Abrigo, Javiera Collinao, Alexandra Espinoza, Sabrina Valenzuela, Bielka Carvajal, Gabriel Prado, Rebeca Peralta, Martin Gotteland, Martin Gotteland
Publicado em 2020-06-01
Assuntos:
“...non-caloric sweeteners...”Publicado em 2020-06-01
Obter o texto integral
Artigo
11
Por Sambra, Verónica, López-Arana, Sandra, Cáceres, Paola, Abrigo, Karen, Collinao, Javiera, Espinoza, Alexandra, Valenzuela, Sabrina, Carvajal, Bielka, Prado, Gabriel, Peralta, Rebeca, Gotteland, Martin
Publicado no Front Nutr (2020)
“..., compared to other countries. 67.1% of the dairy products, 31.5% of the cereal products, 49...”Publicado no Front Nutr (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Matsuse, Hiroto, Tsuchida, Tomoko, Fukahori, Susumu, Kawano, Tetsuya, Tomari, Shinya, Matsuo, Nobuko, Nishino, Tomoya, Fukushima, Chizu, Kohno, Shigeru
Publicado em 2013
“... years; male/female ratio, 117:204) over 1 year. Results were compared between patients who had been...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... compartmental model of MRSA fate, transport, and exposure between two hypothetical hospital rooms: one with a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Brady, Christopher J, Villanti, Andrea C, Law, Hua Andrew, Rahimy, Ehsan, Reddy, Rahul, Sieving, Pamela C, Garg, Sunir J, Tang, Johnny
Publicado no Cochrane Database Syst Rev (2016)
“...), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid...”Publicado no Cochrane Database Syst Rev (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Salazar, Miguel Antonio, Pesigan, Arturo, Law, Ronald, Winkler, Volker
Publicado no Glob Health Action (2016)
“...) by calculating daily post-disaster consultation rates for up to 150 days post-disaster. These were compared over...”Publicado no Glob Health Action (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“...Timothy S Leung,1 Ernest H Law2 1Faculty of Pharmaceutical Sciences, University of British...”
Obter o texto integral
Obter o texto integral
Artigo
17
Por McDonald, Paul C., Chia, Stephen, Bedard, Philippe L., Chu, Quincy, Lyle, Michael, Tang, Liren, Singh, Madhu, Zhang, Zaihui, Supuran, Claudiu T., Renouf, Daniel J., Dedhar, Shoukat
Publicado no Am J Clin Oncol (2020)
“... mg oral daily dosing of SLC-0111 in cohort 1 and increased to 1000 and 2000 mg in cohorts 2 and 3...”Publicado no Am J Clin Oncol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Alkharashi, Majed, Lindsley, Kristina, Law, Hua Andrew, Sikder, Shameema
Publicado no Cochrane Database Syst Rev (2015)
“... Trials Register) (2015, Issue 1), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations...”Publicado no Cochrane Database Syst Rev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Fowler, Nathan H., Samaniego, Felipe, Jurczak, Wojciech, Ghosh, Nilanjan, Derenzini, Enrico, Reeves, James A., Knopińska-Posłuszny, Wanda, Cheah, Chan Y., Phillips, Tycel, Lech-Maranda, Ewa, Cheson, Bruce D., Caimi, Paolo F., Grosicki, Sebastian, Leslie, Lori A., Chavez, Julio C., Fonseca, Gustavo, Babu, Sunil, Hodson, Daniel J., Shao, Spencer H., Burke, John M., Sharman, Jeff P., Law, Jennie Y., Pagel, John M., Miskin, Hari P., Sportelli, Peter, O'Connor, Owen A., Weiss, Michael S., Zinzani, Pier Luigi
Publicado no J Clin Oncol (2021)
“...) indolent non-Hodgkin lymphoma (iNHL). PI3K inhibitors have been hampered by poor long-term tolerability...”Publicado no J Clin Oncol (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Edward Oluwatobi POLUYI, Oluwakemi Ololade ODUKOY, Bolajoko AINA, Babalola FASERU
Publicado no Pharmacy Practice (2015)
“...%) ethnicity and had been practicing pharmacy for ten years or less (72.2%). A majority (90.1%) of respondents...”Publicado no Pharmacy Practice (2015)
Obter o texto integral
Artigo